Advertisement
Advertisement

SER

SER logo

Serina Therapeutics, Inc.

2.78
USD
Sponsored
+0.11
+4.12%
Aug 11, 16:00 UTC -4
Closed
exchange

After-Market

2.77

-0.01
-0.22%

Serina Therapeutics, Inc. Profile

About

Serina Therapeutics Inc. is a privately-held, clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson's Disease and other neurological diseases. Serina Therapeutics Inc., formerly known as AgeX Therapeutics Inc., is based in HUNTSVILLE, Ala.

Info & Links

CEO

Steve Ledger

Headquarters

601 GENOME WAY, SUITE 2001
HUNTSVILLE, AL 35806, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://serinatherapeutics.com

Auditor

Frazier & Deeter, LLC

Share holders

96

Employees

16

Serina Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

41.60M

Enterprise Value

20.09M

Enterprise Value/EBITDA(ttm)

-0.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.82

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-1240.00%

Return on Equity(ttm)

-8051.54%

Return on Invested Capital(ttm)

-828.96%

Return on Assets(ttm)

-155.08%

Income Statement

Revenue(ttm)

130.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

130.00K

EBITDA(ttm)3

-24.25M

Net Income Available to Common(ttm)

-21.27M

Diluted EPS(ttm)

-2.00

Share Statistics

Beta (5Y Monthly)

1.11

52-Week Change

-49.55%

S&P 500 52-Week Change

21.26%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

15.00M

Dividend Yield

0.00%

Float4

12.34M

% Held by Insiders

17.70%

% Held by Institutions

12.50%

Balance Sheet

Total Cash(mrq)

24.53M

Total Cash Per Share(mrq)

1.64

Total Debt(mrq)

3.01M

Total Debt/Equity(mrq)

17.08%

Current Ratio(mrq)

4.18%

Quick Ratio(mrq)

4.18%

Book Value Per Share(mrq)

1.18

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-4.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement